TRACERx 100: RNAseq data from the first 100 TRACERx tumours
TRACERx (TRAcking Cancer Evolution through therapy (Rx)) is a prospective cohort study designed to investigate intratumor heterogeneity (ITH) in relation to clinical outcome, and to determine the clonal nature of driver events and evolutionary processes in early stage non-small cell lung cancer (NSCLC). This study looks at the multi-region RNAseq data from the TRACERx100 cohort with high enough quality RNA available. There is RNAseq data from 164 regions (64 patients).
- Type: Other
- Archiver: EGA European Genome-Phenome Archive
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
|EGAD00001004591||Illumina HiSeq 4000||164|
Neoantigen-directed immune escape in lung cancer evolution.
Nature 567: 2019 479-485
Understanding the impact of immune-mediated selection on lung cancer evolution.
Br J Cancer 124: 2021 1615-1617
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression.
Nat Biotechnol 40: 2022 1624-1633
The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer.
Nat Cancer 4: 2023 608-628